Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on World Healthcare Report.
Press releases published on August 12, 2025
Senior Housing Leads Commercial Real Estate in Occupancy Gains, Reinforcing Long-Term Outlook for SLF Investments
EIN Presswire
·
August 12, 2025
Latest NIC data confirms senior housing as the top-performing CRE sector in occupancy gains, aligning with SLF Investments’ growth strategy and market outlook LENEXA, KS, UNITED STATES, August 11, 2025 /EINPresswire.com/ -- New data released in the May …
SLF Investments Reports First-Quarter Revenue Growth With Strong Outlook for Second Half of 2025
EIN Presswire
·
August 12, 2025
Private equity firm sees rising occupancy and improved operational performance drive early-year revenue gains, with strong momentum projected into Q3 2025. LENEXA, KS, UNITED STATES, August 11, 2025 /EINPresswire.com/ -- SLF Investments is a private …
6 Ways U.S. Tariff Policy Can Affect Sales Taxes And Corporate Decision-Making
EIN Presswire
·
August 12, 2025
Beyond adding to product cost, tariffs can also have an influence on sales taxes and sales tax nexus qualifications, which can affect other business decisions. PHILADELPHIA, PA, UNITED STATES, August 12, 2025 /EINPresswire.com/ -- Earlier this year, …
Healthark Announces RWEsearch & Health Innovation Summit 2025 – A Global Virtual Gathering from September 9-11, 2025
EIN Presswire
·
August 12, 2025
Healthark announces RWEsearch …
iPETcertum™ by Claritas, Developed with Cutting-Edge Technology for Enhancement, Automated Segmentation and Accurate Quantification in PET, PET-CT/MRI Scans, Receives FDA Clearance
GlobeNewswire
·
August 12, 2025
LONDON and NEW YORK, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Claritas NucMed Technologies Ltd (Claritas), a healthcare technology company specializing in state-of-the-art signal processing, quantification and AI technologies for the nuclear medicine industry, is …
Ligand Announces Pricing of $400 Million Convertible Senior Notes Offering
GlobeNewswire
·
August 12, 2025
JUPITER, Fla., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) (“Ligand”) announced today the pricing of $400.0 million aggregate principal amount of 0.75% convertible senior notes due 2030 (the “notes”) in a private …